medicalxpress - Australians have seen a flurry of headlines announcing the arrival of blood tests for Alzheimer's disease.
AI Summary: New blood tests detecting Alzheimer’s biomarkers are reaching clinical availability, promising earlier and less invasive diagnosis. Clinicians and consumers now face decisions about who should be tested, how to interpret results, and what interventions — if any — follow a positive biomarker. The tests shift diagnostic practice while raising ethical and counseling challenges.
Novel brain 'waste‑map' reveals clearance routes tied to Alzheimer's / 2 months
Blood test predicts Alzheimer’s risk years before symptoms emerge / 19 days
First‑ever smell map reveals surprising organization and Alzheimer links / 3 months
New tests could finally shorten the endometriosis diagnostic saga / 24 days
Grail’s Galleri blood test misses UK study goal; investor jitters / 5 months
UCLA unveils low-cost blood test to detect multiple cancers from one sample / 3 months
Smallpox DNA found in Chilean mummies, tracing colonial disease arrival / 3 days
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.